NLS PHARMACEUTICS LTD (NLSP) Stock Overview
NASDAQ:NLSP - CH1384053976 - Common Stock
NLSP Key Statistics, Chart & Performance
The current stock price of NLSP is 2.22 USD. In the past month the price increased by 10.45%. In the past year, price decreased by -62.78%.
NLSP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.46 | 694.86B | ||
| JNJ | JOHNSON & JOHNSON | 17.68 | 425.77B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.55 | 250.79B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18 | 247.82B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.34 | 245.64B | ||
| MRK | MERCK & CO. INC. | 10.92 | 209.99B | ||
| PFE | PFIZER INC | 7.4 | 142.54B | ||
| SNY | SANOFI-ADR | 11.39 | 122.22B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.08 | 96.95B | ||
| GSK | GSK PLC-SPON ADR | 8.87 | 80.45B | ||
| ZTS | ZOETIS INC | 24.98 | 68.86B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 51.24 | 46.93B |
Related stock screener links
About NLSP
Company Profile
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 3 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
Company Info
NLS PHARMACEUTICS LTD
The Circle 6
Zurich ZUERICH CH-6370 CH
CEO: Alexander Zwyer
Employees: 7
Phone: 41445122150
NLS PHARMACEUTICS LTD / NLSP FAQ
What is the stock price of NLS PHARMACEUTICS LTD today?
The current stock price of NLSP is 2.22 USD. The price increased by 3.74% in the last trading session.
What is the ticker symbol for NLS PHARMACEUTICS LTD stock?
The exchange symbol of NLS PHARMACEUTICS LTD is NLSP and it is listed on the Nasdaq exchange.
On which exchange is NLSP stock listed?
NLSP stock is listed on the Nasdaq exchange.
What is NLS PHARMACEUTICS LTD worth?
NLS PHARMACEUTICS LTD (NLSP) has a market capitalization of 7.99M USD. This makes NLSP a Nano Cap stock.
How many employees does NLS PHARMACEUTICS LTD have?
NLS PHARMACEUTICS LTD (NLSP) currently has 7 employees.
What are the support and resistance levels for NLS PHARMACEUTICS LTD (NLSP) stock?
NLS PHARMACEUTICS LTD (NLSP) has a support level at 2.13 and a resistance level at 2.76. Check the full technical report for a detailed analysis of NLSP support and resistance levels.
Should I buy NLS PHARMACEUTICS LTD (NLSP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NLSP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NLSP, evaluating the profitability, health, valuation and growth aspects
- NLS PHARMACEUTICS LTD (NLSP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NLS PHARMACEUTICS LTD (NLSP) Sales and EPS estimates to see what analysts future expectations are.
- NLS PHARMACEUTICS LTD (NLSP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NLS PHARMACEUTICS LTD (NLSP) Insider and Institutional Ownership to learn about the owners and their transactions.
- NLS PHARMACEUTICS LTD (NLSP) Stock Chart to make your own analysis
- NLS PHARMACEUTICS LTD (NLSP) Latest news and press-releases to stay up to date.
Does NLS PHARMACEUTICS LTD (NLSP) stock pay dividends?
NLSP does not pay a dividend.
What is the Price/Earnings (PE) ratio of NLS PHARMACEUTICS LTD (NLSP)?
NLS PHARMACEUTICS LTD (NLSP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.93).
What is the Short Interest ratio of NLS PHARMACEUTICS LTD (NLSP) stock?
The outstanding short interest for NLS PHARMACEUTICS LTD (NLSP) is 4.73% of its float. Check the ownership tab for more information on the NLSP short interest.
NLSP Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to NLSP. When comparing the yearly performance of all stocks, NLSP is a bad performer in the overall market: 93.61% of all stocks are doing better.
NLSP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NLSP. NLSP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NLSP Financial Highlights
Over the last trailing twelve months NLSP reported a non-GAAP Earnings per Share(EPS) of -2.93. The EPS increased by 77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -181.68% | ||
| ROE | -288.47% | ||
| Debt/Equity | 0 |